Bundesinstitut für Arzneimittel und Medizinprodukte
General aspects
Session: Going digital (7 May 2013, 11: 15–12: 45) Presented by: Klaus Menges (BfArM), Olivier Simoen (EMA)
Version 01.01
General aspects Session: Going digital (7 May 2013, 11: 1512: 45) - - PowerPoint PPT Presentation
Bundesinstitut fr Arzneimittel und Medizinprodukte General aspects Session: Going digital (7 May 2013, 11: 1512: 45) Presented by: Klaus Menges (BfArM), Olivier Simoen (EMA) Version 01.01 Overview eCTD and NeeS Technical
Session: Going digital (7 May 2013, 11: 15–12: 45) Presented by: Klaus Menges (BfArM), Olivier Simoen (EMA)
Version 01.01
1 Going digital – general aspects
Going digital – general aspects
2
Going digital – general aspects
3
Going digital – general aspects
working documents Word files
“outside” NeeS working documents Word files
Cover letter tracking.pdf
Cover letter tracking.pdf
eu- regional .xml
“outside” NeeS working documents Word files
Cover letter tracking.pdf
4
Going digital – general aspects
5
replace not performed
listed under 5-22
6 Going digital – general aspects
7 Going digital – general aspects
Going digital – general aspects
8
Going digital – general aspects
9
Going digital – general aspects
10
Going digital – general aspects
compliance (version 3.0)
aspects and requirements (version 2.0)
3.0, new versions 5.0 / 4.0 by Sept 1, 2013)
Document (eCTD) in the Mutual Recognition and Decentralised Procedures (version 3.0)
variations, and renewals within MRP , DCP or National procedures (regulary updates published)
Submission
11
Going digital – general aspects
with ICH specifications on m2 to m5 and EU specification on m1 (eCTD)
name or procedure number
a separate folder on root level named < sequence> -workingdocuments
for submissions on CD or DVD
12
Going digital – general aspects
13
Going digital – general aspects
number, Applicant, (ATC-code), Type of submission, Invented name, Active substance, Date sent
14
No restrictions allow ed for passw ord, copy & paste, print
Too long path lengths can easily be avoided
You m ay use the NeeS TOC Builder
15 Going digital – general aspects
− Pass/ Fail − Best Practice (warnings) − No other or additional criteria should be set by any agencies for technical validation
TIGes
16 Going digital – general aspects
Going digital – general aspects
Seite 17
17
Going digital – general aspects
− Special note on “Y” criteria: Never operate on a commonly submitted document in a national submission – never operate on a nationally submitted document in a common submission
should be reported as invalid and an technically corrected submission should be submitted by the applicant – using the same sequence number
18
explained in the cover letter/ reviewer's guide or in an added note to the submission (to prevent changing the MD5 checksum)
the agency during technical validation (if no "Fail" in the P/ F-test)
are not explained by the applicant
Going digital – general aspects 19
20 Going digital – general aspects
all member states concerned.
distributed
21 Going digital – general aspects
22 Going digital – general aspects
23 Going digital – general aspects
Going digital – general aspects
24
submissions
25 Going digital – general aspects
Info submitted Validation and assessment Info published
EU28: Science, Medicines, Health - A regulatory system fit for the future: Going Digital 26
Electronic submission Centralised Procedure (e.g.) SMOP or Refusal Q&A EPAR CxMP Meeting Docs EC Decision …
AR CHMP Opinion
(incl Annex A and I-IV)
…
Medicines Under Eval Information via AtD Future: Proactively Published Info